本文選題：intraocular　切入點：lymphoma　出處：《International Journal of Ophthalmology》2017年08期 　論文類型：期刊論文

【摘要】：Intraocular lymphoma(IOL) is a rare lymphocytic malignancy which contains two main distinct forms. Primary intraocular lymphoma(PIOL) is mainly a subtype of primary central nervous system lymphoma(PCNSL). Alternatively,IOL can originate from outside the central nervous system(CNS) by metastasizing to the eye. These tumors are known as secondary intraocular lymphoma(SIOL). The IOL can arise in the retina,uvea,vitreous,Bruch's membrane and optic nerve. There are predominantly of B-cell origin; however there are also rare T-cell variants. Diagnosis remains challenging for ophthalmologists and pathologists,due to its ability to masquerade as noninfectious or infectious uveitis,white dot syndromes,or occasionally as other metastatic cancers. Laboratory tests include flow cytometry,immunocytochemistry,interleukin detection(IL-10: IL-6,ratio 1),and polymerase chain reaction(PCR) amplification. Methotrexate-based systemic chemotherapy with external beam radiotherapy and intravitreal chemotherapy with methotrexate are useful for controlling the disease,but the prognosis remains poor. Therefore,it is important to make an early diagnose and treatment. This review is focused on the clinical manifestations,diagnosis,treatment and prognosis of the IOL.
[Abstract]:Intraocular lymphoma(IOL) is a rare lymphocytic malignancy which contains two main distinct forms. Primary intraocular lymphoma(PIOL) is mainly a subtype of primary central nervous system lymphoma(PCNSL). Alternatively,IOL can originate from outside the central nervous system(CNS) by metastasizing to the eye. These tumors are known as secondary intraocular lymphoma(SIOL). The IOL can arise in the retina,uvea,vitreous,Bruch's membrane and optic nerve. There are predominantly of B-cell origin; however there are also rare T-cell variants. Diagnosis remains challenging for ophthalmologists and pathologists,due to its ability to masquerade as noninfectious or infectious uveitis,white dot syndromes,or occasionally as other metastatic cancers. Laboratory tests include flow cytometry,immunocytochemistry,interleukin detection(IL-10: IL-6,ratio 1),and polymerase chain reaction(PCR) amplification. Methotrexate-based systemic chemotherapy with external beam radiotherapy and intravitreal chemotherapy with methotrexate are useful for controlling the disease,but the prognosis remains poor. Therefore,it is important to make an early diagnose and treatment. This review is focused on the clinical manifestations,diagnosis,treatment and prognosis of the IOL.
【作者單位】： Department
【基金】：Supported by the National Natural Science Foundation of China(No.30371515)
【分類號】：R739.7

【相似文獻】

相關期刊論文 前2條

1 趙坦泰;李云琴;唐羅生;魏欣;朱小華;;Two Cases of Primary Intraocular Lymphoma:Fine Needle Aspiration Diagnosis and Intravitreal Methotrexate Treatment[J];Journal of Huazhong University of Science and Technology(Medical Sciences);2011年01期

2 Xibin Zhou;Houbin Huang;Yifei Huang;;Presumed Acquired Retinal Astrocytoma in Association with Anterior Uveitis[J];Eye Science;2013年01期

，

本文編號：1590142